PROFIL PENGOBATAN KEMOTERAPI PADA PASIEN KANKER PAYUDARA DI RUMAH SAKIT UMUM DAERAH KOTA BOGOR PADA TAHUN 2022
DOI:
https://doi.org/10.33759/jrki.v6i3.491Keywords:
Kanker Payudara, Kemoterapi, Profil PengobatanAbstract
Breast cancer is cancer that starts in the breast tissue, which consists of milk-producing glands (lobules) and ducts that connect the lobules to the nipple. One of the efforts to reduce the morbidity rate of breast cancer is chemotherapy. Chemotherapy involves the use of cytostatic drugs aimed at stopping the growth and spread of cancer cells. The purpose of this study was to determine the pattern of drug use and evaluation of drug use in breast cancer patients. The study was conducted observational with retrospective data collection. The research was conducted from May to June 2023. The number of samples was 96 samples with the method of purposive sampling technique using the slovin formula, the data were analyzed qualitatively. The results of the chemotherapy treatment profile using single therapy 9 patients (9.38%), combination therapy 87 patients (90.63%) with a combination chemotherapy regimen of Epirubicin and Cyclophosphamide followed by Paclitaxel as many as 50 patients (57.47%). Evaluation of appropriate patient (98.96%), appropriate indication (100%), appropriate drug (100%), appropriate dose (19.79%), inappropriate dose (20.83%), under dose (34.48%), over dose (25%).
Downloads
References
Alteri, R., Kalidas, M., Gadd, L., & Stump-Sutliff, K. (2016). Breast Cancer. American Cancer Society, 1–127.
Amelia, K., Rusli, D., & Hikmah, M. (2022). Evaluasi Penggunaan Obat dan Kesesuaian Dosis Kemoterapi Body Surface Area (BSA) Pasien Kanker Payudara di RSUD Sekayu. Pharmaceutical Journal of Islamic Pharmacy, 6(2), 56.
Arisanti, J. P., Saptarina, N., & Andarini, Y. D. (2020). Evaluasi Penggunaan Obat Kemoterapi Pada Penderita Kanker Payudara Di Rsup Dr. Seoradji Tirtonegoro Periode 2018. Pharmaceutical Journal of Islamic Pharmacy, 4(2), 1.
Boulanger, J., Boursiquot, J. N., Cournoyer, G., Lemieux, J., Masse, M. S., Almanric, K., & Guay, M. P. (2014). Management of hypersensitivity to platinum- and taxane-based chemotherapy: CEPO review and clinical recommendations. Current Oncology, 21(4), 630–641.
Irawati, I., & Sardjan, M. (2022). Pola Peresepan Obat Kemoterapi Kanker Payudara di Rumah Sakit Lavalette Kota Malang. PHARMADEMICA : Jurnal Kefarmasian Dan Gizi, 1(2), 80–85.
Kemenkes, R. (2018). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Payudara. Kementerian Kesehatan Republik Indonesia, 66, 37–39.
Marfianti, E. (2021). Peningkatan Pengetahuan Kanker Payudara dan Ketrampilan Periksa Payudara Sendiri (SADARI) untuk Deteksi Dini Kanker Payudara di Semutan Jatimulyo Dlingo. Jurnal Abdimas Madani Dan Lestari (JAMALI), 3(1), 25–31.
Nuraini, N., Megawati, S., & Wahyuningtyas, D. (2022). Evaluasi Penggunaan Obat Kemoterapi Pada Pasien Kanker Payudara Di Rumah Sakit Umum Kabupaten Tangerang. Jurnal Farmagazine, IX(2), 34–39.
Permenkes. (2015). Peraturan Menteri Kesehatan Republik Indonesia Nomor 34 Tahun 2015 Tentang Penanggulangan Kanker Payudara dan Kanker Leher Rahim. Ekp, 13(3), 1576–1580.
Sukandar, E. Y., Hartini, S., & Rizkita, P. (2014). Evaluasi Reaksi Obat Merugikan pada Pasien Kemoterapi Kanker Payudara di Salah Satu Rumah Sakit di Bandung ( Evaluation of Adverse Effects in Patient with Breast Cancer Chemotherapy at A Hospital in Bandung ). Jurnal Ilmu Kefarmasian Indonesia, 12(2), 183–192.
The Global Cancer Observatory. (2020). Cancer Incident in Indonesia. International Agency for Research on Cancer, 858, 1–2.
Wells, B. G., Dipiro, J. T., Schwinghammer, T. L., & DiPiro, C. V. (2015). Pharmacoterapy A Phatophysiologic Approach. In United State: McGraw-Hill Education.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Riset Kefarmasian Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
